Abstract
Background
The effect of smoking and sex on the relationship between alcohol consumption and risk of developing metabolic syndrome (MetS) and its components has not been investigated.
Methods
A total of 5,629 Korean adults aged 40–69 years without MetS were recruited at baseline. Alcohol consumption was assessed biennially, and participants were classified as never, light, moderate, or heavy drinkers. Smoking status was examined at baseline and categorized into non-smokers and current smokers. Risk of incident MetS and its components according to alcohol consumption was examined by smoking status and sex using a multivariate Cox proportional hazards model.
Results
During a follow-up of 12 years, 2,336 participants (41.5%) developed MetS. In non-smokers, light or moderate alcohol drinkers had a lower risk of developing MetS, abdominal obesity, hyperglycemia, hypertriglyceridemia, and low HDL-C compared with never drinkers. Heavy alcohol consumption was associated with a higher risk of incident elevated blood pressure (hazard ratio [HR] 1.48; 95% confidence interval [CI], 1.07–2.06; P = 0.020) in men and abdominal obesity (HR 1.86; 95% CI, 1.06–3.27; P = 0.030) in women. However, in smokers, the inverse association of light or moderate alcohol consumption with hypertriglyceridemia and abdominal obesity was not present, whereas a positive association between heavy alcohol consumption and hyperglycemia (HR 1.39; 95% CI, 1.07–1.80; P = 0.014) was observed.
Conclusions
Smoking status and sex strongly affects the association between long-term alcohol consumption and MetS and its components by the amount of alcohol consumed.
Key words: long-term alcohol consumption, metabolic syndrome, smoking status, hypertriglyceridemia, prospective study
INTRODUCTION
Metabolic syndrome (MetS) is a complex of metabolic abnormalities, including abdominal obesity, hyperglycemia, hypertriglyceridemia, low levels of high-density lipoprotein cholesterol (HDL-C), and elevated blood pressure.1 MetS is considered a risk factor for development of cardiovascular disease (CVD) and type 2 diabetes mellitus, as well as for all-cause mortality.2 MetS prevalence increased in the American population from 32.9% to 34.7% between 2003–2004 and 2011–2012.3 A recent systemic review found that at least one-fifth of the adult population in the Asia-Pacific region had MetS.4
Lifestyle factors, such as alcohol drinking and smoking, are known to be major risk factors for MetS and its components. Evidence has shown that the association between alcohol consumption and MetS is complex and controversial because the association is reported to differ depending on the amount of alcohol consumed. Light alcohol consumption was inversely associated with MetS and heavy alcohol consumption was positively associated with MetS and its components.5–7 Some studies reported no significant association8,9 or positive association10 between alcohol consumption and MetS. Interactions with cigarette smoking, which tends to be correlated with alcohol intake, may contribute to the conflicting results. Recent studies showed that it is important to account for smoking status when assessing preventability of metabolic diseases.11,12 Several studies have shown the association of cigarette smoking and alcohol consumption with MetS.13–15 However, the interrelationship of alcohol drinking and smoking habit on MetS and its components have not been investigated in the prospective design.
Furthermore, the influence of alcohol consumption on risk of MetS and its components may vary across ethnicity.16 Alcohol may be more sensitive in Asian population than Caucasian due to genetic difference in alcohol-metabolizing enzymes.17 Therefore, the association of long-term alcohol consumption and smoking with metabolic risk factors could be different in Asian populations.
In this context, this study explored the prospective association between long-term alcohol consumption and risk of MetS and its components by smoking status and sex in middle-aged and older adults using data from a large community-based cohort study.
METHODS
Subject population
Data from the Korean Genome and Epidemiology Study (KoGES) was used for this study. KoGES is an ongoing prospective cohort study to explore genetic, diet, and environmental factors related to CVD and diabetes mellitus in the Korean general population.18 A total of 10,030 participants, aged 40–69 years, living in Ansan and Ansung City were recruited between 2001 and 2002 at baseline. Questionnaires collected demographic information, medical history, and lifestyle factors at baseline. Anthropometric measurements and biochemical data for MetS diagnosis were collected biennially from 2003 to 2014.
Among the 10,030 participants, exclusion criteria included: had MetS or its components at baseline, refused to participate in follow-up examinations, had CVD or cancer at baseline, did not complete the alcohol consumption questionnaire, were missing information on covariates, or were past drinkers. Included in the analyses were 5,629 participants (2,884 men and 2,745 women) for MetS, 4,912 participants for abdominal obesity, 6,528 participants for hyperglycemia, 5,064 participants for hypertriglyceridemia, 4,996 participants for low HDL cholesterol, and 4,514 participants for elevated blood pressure (eFigure 1).
This study has been carried out in accordance with Declaration of Helsinki. The study protocol was approved by the Institutional Review Boards of the Korea Centers for Disease Control and Prevention and Kyung Hee University (KHSIRB-16-022). Written informed consent was obtained from all participants.
Definition of MetS
MetS incidence was measured biennially. The diagnostic criteria for MetS were presence of three or more of19: (1) abdominal obesity, defined as waist circumference ≥90 cm in men or ≥80 cm in women; (2) hyperglycemia, defined as fasting blood glucose ≥100 mg/dL, current use of insulin or oral hypoglycemic medication, or physician’s diagnosis; (3) hypertriglyceridemia, defined as plasma triglyceride (TG) concentration ≥150 mg/dL; (4) low HDL-C, defined as plasma HDL-C concentration <40 mg/dL in men or <50 mg/dL in women; and (5) elevated blood pressure, defined as systolic blood pressure (SBP) ≥130 mm Hg, diastolic blood pressure (DBP) ≥85 mm Hg, use of antihypertensive medication, or physician’s diagnosis of hypertension.
Alcohol consumption
Alcohol consumption was biennially evaluated via questionnaire-based interview using a standardized manual. Alcohol consumption was asked about with question “How often did you drink alcohol during the past year?” For the assessment of habitual alcohol intake, alcohol consumption was calculated as the average of baseline and all follow-up examinations right before the MetS was assessed.
Six types of alcoholic beverages, including traditional beverages (such as soju, chungju, and makgeolli), beer, wine, and hard liquor were examined. Alcohol consumption was evaluated among current and former drinkers who consumed alcohol within 1 year. Participants were asked to state the average frequency and portion size of alcohol drinks during the past year. Frequency had six options (once/month, 2–3 times/month, once/week, 2–3 times/week, 4–6 times/week, once/day). Portion size of drinks was determined with an open-ended question. The volume of one standard drink was described in the question as depending on alcohol type (beer: 220 cc, wine: 90 cc, hard liquor: 30 cc, soju: 50 cc, chungju: 50 cc, makgeolli: 240 cc). Consumption of each drink was calculated as frequency of alcohol drink multiplied by portion size and converted to alcohol consumption. Specific alcohol consumption in g/d was calculated based on alcohol content (4.5% beer, 12% wine, 40% hard liquor, 22% soju, 16% chungju, and 6% makgeolli). Total alcohol consumption was calculated by summing alcohol consumption from six alcohol drinks. Never drinkers are individuals who had never drank during life time. Past drinkers are individuals who stopped drinking alcohol before two years at each examination were excluded from the analysis because of small number (n = 127). Alcohol consumption was categorized into four groups based on World Health Organization criteria20 as: (1) never drinker; (2) light (0–15 g/day men, 0–10 g/day women); (3) moderate (15<–40 g/day men, 10<–20 g/day women); and (4) heavy (>40 g/day men, >20 g/day women).
Anthropometric measurements and biochemical assessments
Health examinations were conducted by trained research staff using a standardized protocol. Height and body weight were measured at baseline while participants wore a thin cloth and socks without shoes. Body mass index (BMI) was calculated as body weight (kg) divided by the square of height (m2). Waist circumference was measured at the midpoint between the lowest rib and the iliac crest and the average of three repeated measurements was used. Blood pressure was measured using a mercury sphygmomanometer (W.A Baum Co. Inc., Copiague, NY, USA) with patients in a sitting position after 5 minutes of relaxing. SBP and DBP were measured twice at phase I Korotkoff sound for SBP and phase V for DBP and reported as the average of both arm readings. Blood samples were collected after at least 8 hours fasting and plasma was separated for biochemical measurements. Plasma concentrations of glucose, TG, and HDL-C were enzymatically measured using an autoanalyzer (ADIVA 1650, Bayer HealthCare, Tarrytown, NY, USA).
Covariates
Data on demographic characteristics, socioeconomic status, and lifestyle factors were examined at baseline using structured questionnaires.21 Monthly household income was categorized into four groups: <$890 (approximately 1 million Korean won in 2018), $890 to <$1,780, $1,780 to <$2,670, and ≥$2,670. Educational level was categorized into three groups; ≤6, 7 to ≤12, and >12 years. Smoking status was categorized into three groups: never, former, and current smoker. Non-smoker included never smoker and former smoker. Former and current smokers were asked about smoking duration. Physical activity was evaluated using metabolic equivalent of task-hours per day.22 Participants were asked about hours spent on sleep and activities classified according to intensity: sedentary, very light, light, moderate, and heavy activity.
Dietary intake was assessed at baseline and second follow-up examination (2005–2006) with a validated semi-quantitative food frequency questionnaire (FFQ).23 For participants who developed MetS or were censored between baseline and second follow-up, food consumption was evaluated based on FFQ at baseline. For those who developed MetS or were censored after second follow-up, food consumption was calculated based on the average of FFQs at baseline and second follow-up. Intake of 12 types of fruit, meat (pork, beef, chicken, and processed meat), refined grains (white rice, noodles, and breads), whole grains (barley, multigrain, and mixed grain powder), and dairy foods (including milk and yogurt) were evaluated. Nutrient intake was calculated using a food composition table provided by Korean Nutrition Society.24
Statistical analysis
Characteristics of participants at baseline are expressed as mean and standard deviation (continuous variables) or number and percentage (categorical variables). Differences in characteristics according to development of MetS were examined using chi-square tests for categorical variables and Student’s t-tests for continuous variables. Comparisons of variables across four categories of alcohol consumption were made using either chi-square tests or generalized linear models, as appropriate. Hazard ratios (HRs) and 95% confidence intervals (CIs) for risk of MetS and its components according to alcohol consumption were calculated using multivariate Cox proportional hazards models. Alcohol drinking status was categorized into four groups and never drinkers were the reference group. Three models were fitted as: model 1 adjusted for age; model 2 adjusted for age, residential location, household income, education level, smoking status, physical activity, menopause (for women), and BMI; and model 3 adjusted for all covariates in model 2 plus energy intake and food intake (fruits, meat, refined grain, whole grain, and dairy products). To select variables for adjustment in the multivariable model, potential confounders from the literature were accounted for with statistical approaches, such as stepwise procedures or comparing adjusted and unadjusted effect estimates of potential confounders.25 Tests for linear trends were based on the median value of each category. Stratified analysis was conducted because of interactions between alcohol consumption and sex (P < 0.0001) or smoking status (non-smoker/current smoker) or residential location (rural/urban). Logistic regression analysis was used to examine the effect of interaction between alcohol consumption and smoking status on hypertriglyceridemia by the category of alcohol consumption.
The proportional hazard assumption was confirmed graphically using log–log plots and statistically using Schoenfeld’s residuals26 with no violation of the assumption. Person-year was estimated as the actual time at risk-between the start date of study and the end date of study (date of disease incidence, date of loss to follow-up, date of end of study), in days, that all participants contributed to a study, and then converted to years. All data were analyzed using SAS software, version 9.4 (SAS Institute, Cary, NC, USA). P < 0.05 was considered statistically significant for two-sided tests.
RESULTS
The follow-up rate was 73% for 42,785 person-years. The average follow-up period was 91 months (range, 17–151 months). A total of 2,336 (41.5%) participants acquired MetS during the follow-up period.
Baseline characteristics of the study population according to incidence of MetS by sex are in Table 1. Men who developed MetS were more likely to live in rural areas and to be current smokers. They had higher BMI and higher intake of total energy, meat, refined grains. They had less intake of whole grains and dairy products compared to those who did not develop MetS. Women who developed MetS were older and more likely to live in rural areas. They had lower income, were less educated and had higher physical activity and BMI. They had higher intake of energy from carbohydrate and refined grains and lower intake of energy from protein and fat, fruits, meat, whole grains, and dairy products compared to those who did not develop MetS.
Table 1. Baseline characteristics of Korean adults according to development of metabolic syndrome.
MetS (n = 2,336) |
Non-MetS (n = 3,293) |
P value | |
Men (n = 2,884) | |||
n (%) | 1,122 (38.9) | 1,762 (61.1) | |
Age, years | 51.1 (8.3) | 51.1 (8.9) | 0.918 |
Area of residence, n (%) | <0.0001 | ||
Rural, Ansung | 549 (48.9) | 718 (40.7) | |
Urban, Ansan | 573 (51.1) | 1,044 (59.3) | |
Household income, n (%) | 0.811 | ||
<$890/month | 301 (26.8) | 463 (26.3) | |
$890 to <$1,780 | 346 (30.8) | 532 (30.2) | |
$1,780 to <$2,670 | 220 (19.6) | 372 (21.1) | |
≥$2,670 | 255 (22.8) | 395 (22.4) | |
Education level, n (%) | 0.400 | ||
≤6 years | 207 (18.5) | 348 (19.8) | |
7 to ≤12 years | 671 (59.8) | 1,009 (57.2) | |
>12 years | 244 (21.7) | 405 (23.0) | |
Smoking status, n (%) | 0.006 | ||
Never smokers | 199 (17.7) | 384 (21.8) | |
Former smokers | 324 (28.9) | 534 (30.3) | |
Current smokers | 599 (53.4) | 844 (47.9) | |
Physical activity | |||
MET, hours/day | 24.8 (15.8) | 24.4 (15.4) | 0.502 |
BMI, kg/m2 | 24.6 (2.5) | 22.9 (2.6) | <0.0001 |
Alcohol intake, % | <0.0001 | ||
Never | 211 (18.8) | 297 (16.9) | |
Light | 369 (32.9) | 781 (44.3) | |
Moderate | 334 (29.8) | 449 (25.5) | |
Heavy | 208 (18.5) | 235 (13.3) | |
Total energy intake, kcal/day | 2,065 (753) | 2,000 (616) | 0.015 |
Percent from energy, % | |||
Carbohydrates | 70.4 (7.3) | 70.6 (6.9) | 0.344 |
Protein | 13.9 (2.4) | 13.7 (5.1) | 0.163 |
Fat | 15.8 (5.4) | 15.7 (5.1) | 0.508 |
Food intake, servings/day | |||
Fruits | 2.5 (2.3) | 2.6 (2.1) | 0.107 |
Meat | 0.7 (0.7) | 0.6 (0.5) | 0.003 |
Refined grains | 2.3 (1.6) | 2.2 (1.5) | 0.031 |
Whole grains | 1.6 (1.5) | 1.7 (1.4) | 0.117 |
Dairy | 0.5 (0.6) | 0.6 (0.6) | 0.074 |
Women (n = 2,745) | |||
n (%) | 1,214 (44.2) | 1,531 (55.8) | |
Age, years | 53.1 (8.7) | 48.3 (7.9) | <0.0001 |
Area of residence, n (%) | <0.0001 | ||
Rural, Ansung | 724 (59.6) | 495 (32.3) | |
Urban, Ansan | 490 (40.4) | 1,036 (67.7) | |
Household income, n (%) | <0.0001 | ||
<$890/month | 529 (43.6) | 389 (25.4) | |
$890 to <$1,780 | 370 (30.5) | 469 (30.6) | |
$1,780 to <$2,670 | 174 (14.3) | 357 (23.3) | |
≥$2,670 | 141 (11.6) | 316 (20.7) | |
Education level, n (%) | <0.0001 | ||
≤6 years | 568 (46.8) | 401 (26.2) | |
7 to ≤12 years | 584 (48.1) | 977 (63.8) | |
>12 years | 62 (5.1) | 153 (10.0) | |
Smoking status, n (%) | 0.621 | ||
Never smokers | 1,162 (95.7) | 1,464 (95.6) | |
Former smokers | 14 (1.2) | 13 (0.9) | |
Current smokers | 38 (3.1) | 54 (3.5) | |
Physical activity | |||
MET, hours/day | 23.7 (15.1) | 20.7 (13.1) | <0.0001 |
BMI, kg/m2 | 25.0 (3.0) | 23.3 (2.8) | <0.0001 |
Alcohol intake, % | <0.0001 | ||
Never | 753 (62.0) | 806 (52.7) | |
Light | 414 (34.1) | 662 (43.2) | |
Moderate | 36 (3.0) | 42 (2.7) | |
Heavy | 11 (0.9) | 21 (1.4) | |
Total energy intake, kcal/day | 1,912 (785) | 1,901 (696) | 0.692 |
Percent from energy, % | |||
Carbohydrates | 73.1 (7.2) | 71.3 (7.1) | <0.0001 |
Protein | 13.4 (2.3) | 13.8 (2.3) | <0.0001 |
Fat | 13.5 (5.4) | 14.9 (5.3) | <0.0001 |
Food intake, servings/day | |||
Fruits | 3.2 (2.9) | 3.5 (2.6) | 0.019 |
Meat | 0.4 (0.5) | 0.5 (0.6) | 0.016 |
Refined grains | 1.6 (1.5) | 1.4 (1.2) | <0.0001 |
Whole grains | 1.8 (1.4) | 1.9 (1.2) | 0.013 |
Dairy | 0.7 (0.7) | 0.7 (0.7) | 0.001 |
BMI, body mass index; MET, metabolic equivalent of task; MetS, metabolic syndrome.
Values are n (%) or means (standard deviation).
P values were assessed with Student’s t-test (continuous variables) or chi-square test (categorized variables).
Baseline characteristics of the study population according to alcohol consumption by sex are in Table 2. Men in the highest category of alcohol consumption were younger and more likely to live in urban areas. They were less likely to be educated, had higher income, and were more likely to be current smokers. They had higher physical activity and higher intake of total energy, and energy from protein, fat, and meat. They had lower intake of energy from carbohydrates and fruits compared with never drinkers. Participants in the highest category of alcohol consumption showed significantly higher levels of fasting glucose, TG, HDL-C, SBP, and DBP than never drinkers. Women in the highest category of alcohol consumption were younger, more likely to live in urban areas, and more likely to be educated. They had higher income, were more likely to be current smokers, had lower physical activity, had higher intake of energy from protein, fat, meat, and refined grains, and had lower intake of energy from carbohydrates and whole grains than never drinkers.
Table 2. Baseline characteristics of Korean adults according to alcohol consumption by sex.
Alcohol consumption (g/day) | |||||
Never | Light (0–15) |
Moderate (15<–40) |
Heavy (>40) |
P trend | |
Men | |||||
n (n of cases) | 508 (211) | 1,150 (369) | 783 (334) | 443 (208) | |
Age, years | 53.1 (9.0)a | 51.1 (8.6)b | 50.4 (8.5)b | 50.1 (8.6)b | <0.0001 |
Residential location, % | 0.006 | ||||
Rural, Ansung | 49.4 | 41.6 | 41.9 | 47.4 | |
Urban, Ansan | 50.6 | 58.4 | 58.1 | 52.6 | |
Education level, % | <0.0001 | ||||
≤6 years | 23.4 | 15.7 | 20.1 | 22.4 | |
7 to ≤12 years | 55.5 | 59.5 | 56.6 | 61.2 | |
>12 years | 21.1 | 24.8 | 23.3 | 16.4 | |
Household income, % | <0.0001 | ||||
<$890/month | 33.5 | 23.3 | 24.9 | 29.6 | |
$890 to <$1,780 | 31.7 | 32.1 | 30.9 | 23.9 | |
$1,780 to <$2,670 | 15.6 | 22.3 | 19.4 | 23.7 | |
≥$2,670 | 19.3 | 22.3 | 24.8 | 22.8 | |
Smoking status, % | <0.0001 | ||||
Never | 33.7 | 23.3 | 12.4 | 10.6 | |
Former | 28.2 | 31.6 | 29.9 | 26.6 | |
Current | 38.2 | 45.1 | 57.7 | 62.8 | |
Physical activity | |||||
MET, hours/day | 24.5 (16.2)a,b | 23.8 (15.2)a | 24.4 (15.1)a,b | 26.6 (16.5)b | 0.017 |
BMI, kg/m2 | 23.5 (2.9) | 23.5 (2.6) | 23.7 (2.6) | 23.5 (2.8) | 0.224 |
Alcohol intake, g/day | 0 | 5.1 (0.3–14.5) | 23.7 (15.6–39.4) | 50.9 (40.5–252.0) | |
Nutrient intake | |||||
Total energy, kcal/day | 2,029 (773)a,b | 1,996 (611)a | 2,020 (575)a,b | 2,107 (846)b | 0.032 |
Carbohydrate, % | 71.9 (7.4)a | 70.9 (6.8)b | 69.7 (6.7)c | 69.3 (7.8)c | <0.0001 |
Protein, % | 13.2 (2.4)a | 13.6 (2.2)a | 14.1 (2.1)b | 14.1 (2.6)b | <0.0001 |
Fat, % | 14.9 (5.4)a | 15.5 (5.0)b | 16.2 (5.0)c | 16.4 (5.7)c | <0.0001 |
Food intake, servings/day | |||||
Fruits | 2.8 (3.0)a | 2.7 (2.2)a | 2.4 (1.7)b | 2.3 (1.9)b | <0.0001 |
Meat | 0.5 (0.6)a | 0.6 (0.5)a | 0.7 (0.5)b | 0.8 (0.9)c | <0.0001 |
Refined grains | 2.3 (1.6)a,b | 2.2 (1.5)a | 2.2 (1.6)a,b | 2.4 (1.7)b | 0.029 |
Whole grains | 1.6 (1.5) | 1.7 (1.5) | 1.7 (1.4) | 1.6 (1.5) | 0.531 |
Dairy | 0.5 (0.6) | 0.6 (0.6) | 0.5 (0.7) | 0.5 (0.6) | 0.063 |
Waist circumference, cm | 81.3 (7.6)a,b | 81.2 (6.8)a | 82.1 (6.3)b | 81.9 (6.6)a,b | 0.029 |
Fasting glucose, mg/dL | 90.7 (20.1)a | 89.6 (15.3)a | 91.6 (17.7)a | 94.7 (23.9)b | <0.0001 |
Triglycerides, mg/dL | 129.3 (78.6)a | 136.7 (87.0)a | 149.7 (110.2)b | 169.2 (137.4)c | <0.0001 |
HDL-C, mg/dL | 45.8 (9.5)a | 48.7 (10.7)b | 52.0 (11.7)c | 54.2 (13.1)d | <0.0001 |
SBP, mm Hg | 118.0 (15.7)a,b | 117.6 (15.8)a | 119.6 (16.5)b,c | 121.7 (16.3)c | <0.0001 |
DBP, mm Hg | 78.3 (10.4)a | 79.3 (10.2)a | 80.8 (10.5)b | 82.1 (10.6)b | <0.0001 |
MetS status, % | 41.5 | 32.1 | 42.7 | 47.0 | <0.0001 |
Never | Light (0–10) |
Moderate (10<–20) |
Heavy (>20) |
P trend | |
Women | |||||
n (n of cases) | 1,559 (753) | 1,076 (414) | 78 (36) | 32 (11) | |
Age, years | 52.2 (8.9)a | 48.3 (7.7)b | 47.2 (7.5)b | 44.7 (4.8)b | <0.0001 |
Residential location, % | <0.0001 | ||||
Rural, Ansung | 48.6 | 39.8 | 33.3 | 25.0 | |
Urban, Ansan | 51.4 | 60.2 | 66.7 | 75.0 | |
Education level, % | <0.0001 | ||||
≤6 years | 40.9 | 28.5 | 20.5 | 21.9 | |
7 to ≤12 years | 51.1 | 63.8 | 73.1 | 68.8 | |
>12 years | 8.0 | 7.7 | 6.4 | 9.3 | |
Household income, % | <0.0001 | ||||
<$890/month | 39.5 | 25.8 | 20.5 | 25.0 | |
$890 to <$1,780 | 29.1 | 33.0 | 32.1 | 18.8 | |
$1,780 to <$2,670 | 16.8 | 22.1 | 26.9 | 31.2 | |
≥$2,670 | 14.6 | 19.1 | 20.5 | 25.0 | |
Smoking status, % | <0.0001 | ||||
Never | 97.2 | 94.6 | 82.1 | 90.7 | |
Former | 0.8 | 1.0 | 5.1 | 0 | |
Current | 2.0 | 4.4 | 12.8 | 9.4 | |
Physical activity | |||||
MET, hours/day | 22.7 (14.5) | 21.3 (13.7) | 20.6 (10.1) | 20.0 (14.3) | 0.044 |
BMI, kg/m2 | 24.0 (3.1) | 23.9 (2.9) | 24.7 (3.0) | 24.7 (2.9) | 0.080 |
Alcohol intake, g/day | 0 | 1.7 (0.2–9.8) | 13.3 (10.4–19.4) | 33.4 (20.3–70.3) | |
Nutrient intake | |||||
Total energy, kcal/day | 1,887 (741) | 1,930 (728) | 1,904 (671) | 2,009 (915) | 0.422 |
Carbohydrate, % | 73.1 (7.2)a | 71.2 (6.8)b | 68.2 (8.1)c | 67.1 (8.3)c | <0.0001 |
Protein, % | 13.4 (2.3)a | 13.8 (2.2)b | 14.7 (2.7)c | 14.9 (3.2)c | <0.0001 |
Fat, % | 13.5 (5.3)a | 15.1 (5.1)b | 17.2 (6.0)c | 17.9 (5.7)c | <0.0001 |
Food intake, servings/day | |||||
Fruits | 3.2 (2.7)a | 3.6 (2.7)b | 3.2 (3.2)a,b | 2.9 (2.6)a,b | 0.009 |
Meat | 0.4 (0.5)a | 0.5 (0.6)b | 0.6 (0.5)b | 1.0 (1.2)c | <0.0001 |
Refined grains | 1.6 (1.4)a | 1.4 (1.2)b | 1.4 (1.2)b | 2.0 (1.2)c | 0.035 |
Whole grains | 1.9 (1.3)a | 1.9 (1.3)a | 1.8 (1.2)a,b | 1.1 (1.1)b | 0.004 |
Dairy | 0.7 (0.7) | 0.7 (0.7) | 0.7 (0.7) | 0.7 (0.7) | 0.102 |
Waist circumference, cm | 78.7 (8.9)a | 77.3 (8.4)b | 79.9 (9.0)a,b | 78.7 (8.6)a,b | 0.0003 |
Fasting glucose, mg/dL | 86.3 (13.6) | 85.9 (11.2) | 87.5 (9.5) | 87.7 (6.5) | 0.589 |
Triglycerides, mg/dL | 106.5 (54.9)a | 99.4 (47.7)b | 102.2 (44.8)a,b | 110.2 (40.7)a,b | 0.006 |
HDL-C, mg/dL | 54.2 (11.4) | 55.2 (11.3) | 57.2 (12.0) | 57.9 (10.3) | 0.007 |
SBP, mm Hg | 116.4 (17.9)a | 112.4 (15.9)b | 114.1 (15.1)a,b | 110.8 (15.2)a,b | <0.0001 |
DBP, mm Hg | 76.1 (10.9)a | 74.4 (10.0)b | 76.4 (9.4)a,b | 75.4 (9.7)a,b | 0.001 |
MetS status, % | 48.3 | 38.9 | 46.2 | 34.4 | <0.0001 |
BMI, body mass index; DBP, diastolic blood pressure; HDL-C, high density lipoprotein cholesterol; MET, metabolic equivalent of task; MetS, metabolic syndrome; SBP, systolic blood pressure.
Values are % or means (standard deviation) except for alcohol intake (median (ranges)).
P trend was assessed by generalized linear models or chi-square test.
a,b,c,dDifferences of variables across alcohol consumption were examined by post hoc test (Tukey’s test for multiple comparisons). Unlike superscripts mean significant differences across alcohol consumption.
HRs and 95% CIs for incident MetS and components of MetS according to alcohol consumption by sex are in Table 3. Non-linear association between alcohol consumption and incidence of MetS was observed (Pnon-linearity = 0.04 in men, Pnon-linearity = 0.02 in women). Light alcohol consumption (≤15 g/day in men, ≤10 g/day in women) was associated with a lower risk of incident MetS (HR 0.65; 95% CI, 0.55–0.77; P < 0.0001 for men and HR 0.77; 95% CI, 0.68–0.87; P < 0.0001 women) and all components of MetS in both men and women after adjustment for potential confounders. Moderate alcohol consumption (15–40 g/day in men, 10–20 g/day in women) was associated with a lower risk of incident MetS, abdominal obesity and low HDL-C in men, and low HDL-C in women. Heavy alcohol consumption (>40 g/day for men, >20 g/day for women) was associated with a greater risk of hyperglycemia (HR 1.28; 95% CI, 1.06–1.54; P = 0.010) and elevated blood pressure (HR 1.49; 95% CI, 1.21–1.85; P = 0.0002) and a lower risk of low HDL-C (HR 0.45; 95% CI, 0.37–0.54; P < 0.0001) in men only. For women, heavy alcohol consumption was associated with a greater risk of abdominal obesity (HR 1.77; 95% CI, 1.03–3.05; P = 0.038). No association was seen between heavy alcohol consumption and risk of incident MetS regardless of sex.
Table 3. Hazard ratios and 95% confidence intervals for risk of incident metabolic syndrome components according to alcohol consumption.
Alcohol consumption (g/day) | |||||
Never | Light (0–15) |
Moderate (15<–40) |
Heavy (>40) |
P trend | |
Men | |||||
Abdominal obesity (n = 3,040) | |||||
n (n of cases) | 539 (158) | 1,224 (330) | 829 (256) | 448 (145) | |
Model 1a | 1 | 0.71 (0.59–0.85) | 0.81 (0.67–0.99) | 0.95 (0.76–1.18) | 0.809 |
Model 2b | 1 | 0.72 (0.60–0.87) | 0.78 (0.64–0.95) | 0.90 (0.72–1.12) | 0.616 |
Model 3c | 1 | 0.72 (0.60–0.86) | 0.75 (0.62–0.91) | 0.84 (0.67–1.05) | 0.232 |
Hyperglycemia (n = 2,941) | |||||
n (n of cases) | 546 (241) | 1,221 (444) | 764 (371) | 410 (237) | |
Model 1 | 1 | 0.69 (0.58–0.80) | 1.02 (0.87–1.21) | 1.44 (1.21–1.73) | <0.0001 |
Model 2 | 1 | 0.68 (0.58–0.80) | 0.99 (0.84–1.17) | 1.37 (1.13–1.65) | <0.0001 |
Model 3 | 1 | 0.69 (0.59–0.81) | 0.95 (0.81–1.13) | 1.28 (1.06–1.54) | <0.0001 |
Hypertriglyceridemia (n = 2,130) | |||||
n (n of cases) | 439 (181) | 873 (327) | 537 (262) | 281 (143) | |
Model 1 | 1 | 0.76 (0.63–0.91) | 1.06 (0.88–1.28) | 1.25 (1.00–1.55) | 0.001 |
Model 2 | 1 | 0.74 (0.62–0.89) | 0.97 (0.80–1.18) | 1.12 (0.89–1.40) | 0.042 |
Model 3 | 1 | 0.74 (0.62–0.89) | 0.94 (0.77–1.14) | 1.05 (0.84–1.32) | 0.164 |
Low HDL-C (n = 2,887) | |||||
n (n of cases) | 458 (290) | 1,043 (512) | 872 (390) | 514 (230) | |
Model 1 | 1 | 0.60 (0.52–0.69) | 0.51 (0.44–0.59) | 0.54 (0.45–0.64) | <0.0001 |
Model 2 | 1 | 0.55 (0.48–0.64) | 0.45 (0.39–0.53) | 0.46 (0.39–0.56) | <0.0001 |
Model 3 | 1 | 0.55 (0.48–0.64) | 0.44 (0.38–0.52) | 0.45 (0.37–0.54) | <0.0001 |
Elevated blood pressure (n = 2,031) | |||||
n (n of cases) | 395 (187) | 859 (367) | 492 (232) | 285 (179) | |
Model 1 | 1 | 0.80 (0.67–0.96) | 0.92 (0.76–1.12) | 1.61 (1.31–1.98) | <0.0001 |
Model 2 | 1 | 0.82 (0.68–0.97) | 0.93 (0.76–1.13) | 1.55 (1.25–1.92) | <0.0001 |
Model 3 | 1 | 0.82 (0.68–0.98) | 0.90 (0.74–1.10) | 1.49 (1.21–1.85) | 0.0002 |
Metabolic syndrome (n = 2,884) | |||||
n (n of cases) | 508 (211) | 1,150 (369) | 783 (334) | 443 (208) | |
Model 1 | 1 | 0.66 (0.56–0.78) | 0.93 (0.78–1.10) | 1.15 (0.95–1.40) | 0.001 |
Model 2 | 1 | 0.65 (0.55–0.77) | 0.87 (0.73–1.03) | 1.12 (0.92–1.36) | 0.007 |
Model 3 | 1 | 0.65 (0.55–0.77) | 0.85 (0.71–1.01) | 1.08 (0.88–1.31) | 0.030 |
Never | Light (0–10) |
Moderate (10<–20) |
Heavy (>20) |
P trend | |
Women | |||||
Abdominal obesity (n = 1,872) | |||||
n (n of cases) | 1,079 (586) | 727 (343) | 39 (20) | 27 (14) | |
Model 1 | 1 | 0.78 (0.68–0.89) | 1.02 (0.65–1.60) | 1.28 (0.75–2.18) | 0.027 |
Model 2 | 1 | 0.83 (0.72–0.95) | 1.28 (0.81–2.00) | 1.86 (1.09–3.19) | 0.403 |
Model 3 | 1 | 0.83 (0.72–0.95) | 1.34 (0.85–2.10) | 1.77 (1.03–3.05) | 0.437 |
Hyperglycemia (n = 3,587) | |||||
n (n of cases) | 2,109 (694) | 1,352 (392) | 87 (30) | 39 (15) | |
Model 1 | 1 | 0.86 (0.76–0.97) | 1.27 (0.88–1.84) | 1.87 (1.12–3.13) | 0.686 |
Model 2 | 1 | 0.87 (0.76–0.98) | 1.09 (0.75–1.59) | 1.73 (1.03–2.90) | 0.514 |
Model 3 | 1 | 0.87 (0.76–0.98) | 1.03 (0.71–1.50) | 1.61 (0.96–2.70) | 0.400 |
Hypertriglyceridemia (n = 2,934) | |||||
n (n of cases) | 1,716 (746) | 1,112 (379) | 68 (24) | 38 (18) | |
Model 1 | 1 | 0.68 (0.60–0.77) | 0.81 (0.54–1.22) | 1.27 (0.79–2.03) | <0.0001 |
Model 2 | 1 | 0.69 (0.61–0.79) | 0.77 (0.51–1.17) | 1.20 (0.75–1.93) | <0.0001 |
Model 3 | 1 | 0.70 (0.62–0.79) | 0.76 (0.50–1.15) | 1.11 (0.69–1.78) | <0.0001 |
Low HDL-C (n = 2,109) | |||||
n (n of cases) | 1,302 (961) | 707 (421) | 52 (30) | 48 (30) | |
Model 1 | 1 | 0.60 (0.53–0.67) | 0.66 (0.46–0.95) | 0.76 (0.53–1.09) | <0.0001 |
Model 2 | 1 | 0.60 (0.53–0.67) | 0.64 (0.45–0.93) | 0.76 (0.52–1.09) | <0.0001 |
Model 3 | 1 | 0.60 (0.53–0.68) | 0.63 (0.44–0.91) | 0.69 (0.48–1.00) | <0.0001 |
Elevated blood pressure (n = 2,483) | |||||
n (n of cases) | 1,404 (619) | 991 (346) | 58 (24) | 30 (12) | |
Model 1 | 1 | 0.82 (0.72–0.94) | 1.22 (0.81–1.84) | 1.15 (0.65–2.04) | 0.124 |
Model 2 | 1 | 0.84 (0.73–0.96) | 1.17 (0.77–1.77) | 1.19 (0.67–2.12) | 0.183 |
Model 3 | 1 | 0.84 (0.73–0.96) | 1.11 (0.73–1.68) | 1.12 (0.63–1.99) | 0.123 |
Metabolic syndrome (n = 2,745) | |||||
n (n of cases) | 1,559 (753) | 1,076 (414) | 78 (36) | 32 (11) | |
Model 1 | 1 | 0.76 (0.67–0.86) | 1.08 (0.77–1.51) | 1.06 (0.58–1.92) | 0.004 |
Model 2 | 1 | 0.77 (0.68–0.87) | 0.96 (0.69–1.35) | 1.09 (0.60–1.98) | 0.003 |
Model 3 | 1 | 0.77 (0.68–0.87) | 0.92 (0.66–1.29) | 0.98 (0.54–1.79) | 0.002 |
HDL-C, high density lipoprotein cholesterol.
HRs and 95% CIs for metabolic syndrome and components were obtained using a multivariate Cox proportional hazards model.
aModel 1 was adjusted for age.
bModel 2 was adjusted for age, residential location, household income, education level, smoking status, menopausal status (for women), physical activity, and body mass index.
cModel 3 was adjusted for age, residential location, household income, education level, smoking status, menopausal status (for women), physical activity, body mass index, energy intake, fruit intake, meat intake, refined grain intake, whole grain intake, and dairy intake.
Risk for MetS and its components according to alcohol consumption in men is presented by smoking status in Figure 1. In non-smokers, light or moderate alcohol consumption was inversely associated with MetS and its components including abdominal obesity, hyperglycemia, hypertriglyceridemia, and low HDL-C. Heavy alcohol consumption was associated with a higher risk of elevated blood pressure (HR 1.48; 95% CI, 1.07–2.06; P = 0.020) in men and abdominal obesity (HR 1.86; 95% CI, 1.06–3.27; P = 0.030) in women. Unlike non-smokers, no inverse association of light alcohol consumption with hypertriglyceridemia and abdominal obesity was seen in currently smoking men. Heavy alcohol consumption was associated with a higher risk of hyperglycemia in current smokers (HR 1.39; 95% CI, 1.07–1.80; P = 0.014). In particular, the strong interaction effect of alcohol consumption/smoking on hypertriglyceridemia was observed (Table 4).
Table 4. Hazard ratios and 95% confidence intervals for risk of incident hypertriglyceridemia according to alcohol consumption stratified by smoking status in Korean men.
Alcohol consumption (g/day) | |||||
Never | Light (0–15) |
Moderate (15<–40) |
Heavy (>40) |
P trend | |
Non-smokers (n = 1,120) | |||||
n (n of cases) | 283 (121) | 490 (169) | 238 (102) | 109 (55) | |
Modela | 1 | 0.61 (0.48–0.77) |
0.72 (0.55–0.94) |
0.93 (0.67–1.30) |
0.494 |
P value | <0.0001 | 0.018 | 0.673 | ||
Current smokers (n = 1,010) | |||||
n (n of cases) | 156 (61) | 383 (158) | 299 (160) | 172 (88) | |
Model | 1 | 0.96 (0.71–1.30) |
1.29 (0.96–1.75) |
1.36 (0.97–1.90) |
0.005 |
P value | 0.795 | 0.094 | 0.073 | ||
P for interaction | 0.0057 | <0.0001 | <0.0001 |
aModel was adjusted for age, residential location, household income, education level, physical activity, BMI, energy intake, fruit intake, meat intake, refined grain intake, whole grain intake, and dairy intake.
Risk for MetS and its components according to alcohol consumption by smoking duration in men is in eTable 1. Light alcohol consumption was associated with lower risk of MetS and its components including abdominal obesity, hyperglycemia, hypertriglyceridemia, and low HDL-C regardless of smoking duration. Heavy alcohol consumption was associated with higher risk of hyperglycemia (HR 1.31; 95% CI, 1.04–1.65; P = 0.023) and elevated blood pressure (HR 1.53; 95% CI, 1.19–1.99; P = 0.001) among participants who had more than 20 years of smoking duration.
Additionally, risk for MetS and its components according to alcohol consumption was examined by residential location (data not shown) in men. Light alcohol consumption was inversely associated with MetS and all components in both rural and urban area. Heavy alcohol consumption was positively associated with elevated blood pressure in both areas, and with hyperglycemia in only urban area.
DISCUSSION
This prospective study found that long-term light or moderate alcohol consumption was associated with lower risk of incident MetS, abdominal obesity, hyperglycemia, hypertriglyceridemia, and low HDL-C, and heavy alcohol consumption was associated with higher risk of incident elevated blood pressure for men, and abdominal obesity for women in non-smokers. Unlike non-smoking men, no inverse association of light or moderate alcohol consumption with hypertriglyceridemia and abdominal obesity was seen, whereas a positive association between heavy alcohol consumption and hyperglycemia was observed in smoking men. These results suggest that the association between long term alcohol consumption and risk of developing MetS and its components is substantially affected by smoking status.
Our findings on the association between alcohol intake and MetS or its components are in line with previous studies in white populations. The Quebec Cardiovascular study, during 13 years of follow-up, reported that one drink (<15.2 g/day) was associated with 43% lower risk of developing MetS.27 A longitudinal study among an Italian population aged ≥65 years showed that heavy alcohol consumption (>48 g/day for men, >24 g/day for women) was associated with an increased risk of abdominal obesity, hyperglycemia, and high blood pressure, but not with MetS in men.28
Light or moderate alcohol consumption was associated with lower risk of hypertriglyceridemia in non-smoking men. The beneficial association of alcohol may be explained by the effect of ethanol to decrease TG concentration through the increased activity of lipoprotein lipase.29 A study among an American older population showed significantly lower TG concentrations in individuals who consumed one or two drinks per day compared to non-drinkers.30 However, the inverse relationship between long term alcohol consumption and hypertriglyceridemia was not apparent in currently smoking men. This finding suggest that smoking strongly modifies the relationship between alcohol drinking and TG concentration. Similarly, a cross-sectional study reported that smoking accentuated the elevating effect of heavy alcohol drinking on TG in a male Chinese population suggests strong interactions between alcohol drinking and cigarette smoking on lipid profiles.15 Smoking also affects lipoprotein lipase activity, so it is involved in TG metabolism.31 Previous studies reported that smokers had significantly higher prevalence of hypertriglyceridemia than non-smokers.32,33
Smoking is known to be a risk factor for abdominal visceral fat accumulation.34 This effect could explain the lack of the protective association of light or moderate alcohol consumption on abdominal obesity in smoking men. Moreover, abdominal visceral fat is strongly associated with higher serum TG concentrations.35 Additionally, the effect of smoking on increasing abdominal obesity may be related to cortisol. Nicotine from cigarette smoking elevates cortisol level,36 which may increase fat storage in abdominal or visceral deposit.37 A cross sectional study of British population aged 45–79 years reported that current smokers had higher waist circumference than never smokers.38 Given these results, smoking status should be considered in the analysis on the association between alcohol consumption and lipid metabolism.
On the other hand, heavy alcohol consumption was associated with greater risk of hyperglycemia in current smokers. This phenomenon may be related to insulin resistance. Alcohol induces insulin resistance through abnormalities in signal transduction for glucose uptake.39 A recent study reported that alcohol abstinence significantly reduces fasting blood glucose levels and increases insulin sensitivity in Japanese men who routinely drank alcohol.40 Smoking may aggravate the harmful effects of alcohol intake on glucose level and insulin resistance because smoking itself is an independent risk factor for development of insulin resistance and type 2 diabetes.41 A prospective study with a 5 year follow-up among Japanese men showed an increase in fasting glucose level in current smokers that was significantly higher than never smokers.42 An intervention study found that smokers were less insulin sensitive compared with controls and insulin sensitivity increased after either 1 or 2 weeks of smoking cessation. This result indicates nicotine in tobacco smoke induces insulin resistance in human adults.43 Kim et al reported that length of smoking cessation period independently predicts insulin resistance in Korean male ex-smokers.44 In our study, smoking diminished the beneficial effects of light alcohol consumption on MetS and its components, such as hypertriglyceridemia and abdominal obesity, and deteriorated the unfavorable effect of heavy alcohol consumption on MetS components, such as hyperglycemia.
This study has several strengths. To the best of our knowledge, this is the first study to examine how smoking influences the relation of long-term alcohol consumption on risk of MetS and its components using data from a large population. Also, chronic alcohol consumption was accurately estimated from habitual intake using the average value from repeated measures during a long follow-up (about 10 years). The study adjusted for most major confounders for MetS and its components, including lifestyle and dietary factors. In addition, standardized protocols were used to obtain data on exposure and outcome.
However, this study had some limitations. The association between chronic alcohol consumption and MetS and its components in women might be diminished due to the small number of female heavy alcohol drinkers. There is the possibility that the results could be biased because of loss to follow-up. Although the study adjusted for major confounding factors, residual or unmeasured confounding factors on the association between alcohol consumption and MetS are possible.
In conclusion, long-term alcohol consumption has both beneficial and detrimental effects on MetS and it components depending on the amount of alcohol consumed, and the association is importantly affected by smoking status. Therefore, smoking status should be taken into account in the guideline for alcohol consumption for prevention and management of chronic diseases, including MetS.
ACKNOWLEDGEMENTS
Epidemiological data used in this study were obtained from the Korean Genome and Epidemiology Study (KoGES; 4851-302). This research was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science, and Technology [grant number NRF2016 R1D1A1B039313070].
Conflicts of interest: None declared.
APPENDIX A. SUPPLEMENTARY DATA
The following is the supplementary data related to this article:
eTable 1. The Hazard ratios (HRs) and 95% confidence intervals (CIs) for risk of incident metabolic syndrome components according to alcohol consumption stratified by smoking duration in mena
eFigure 1. Flowchart of study population. HDL-C, high density lipoprotein cholesterol.
REFERENCES
- 1.Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–689. 10.2337/diacare.24.4.683 [DOI] [PubMed] [Google Scholar]
- 2.Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49:403–414. 10.1016/j.jacc.2006.09.032 [DOI] [PubMed] [Google Scholar]
- 3.Aguilar M, Bhuket T, Torres S, et al. Prevalence of the metabolic syndrome in the United States, 2003–2012. JAMA. 2015;313:1973–1974. 10.1001/jama.2015.4260 [DOI] [PubMed] [Google Scholar]
- 4.Ranasinghe P, Mathangasinghe Y, Jayawardena R, et al. Prevalence and trends of metabolic syndrome among adults in the Asia-Pacific region: a systematic review. BMC Public Health. 2017;17:101. 10.1186/s12889-017-4041-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Clerc O, Nanchen D, Cornuz J, et al. Alcohol drinking, the metabolic syndrome and diabetes in a population with high mean alcohol consumption. Diabet Med. 2010;27:1241–1249. 10.1111/j.1464-5491.2010.03094.x [DOI] [PubMed] [Google Scholar]
- 6.Barrio-Lopez MT, Bes-Rastrollo M, Sayon-Orea C, et al. Different types of alcoholic beverages and incidence of metabolic syndrome and its components in a Mediterranean cohort. Clin Nutr. 2013;32:797–804. 10.1016/j.clnu.2012.12.002 [DOI] [PubMed] [Google Scholar]
- 7.Stoutenberg M, Lee DC, Sui X, et al. Prospective study of alcohol consumption and the incidence of the metabolic syndrome in US men. Br J Nutr. 2013;110:901–910. 10.1017/S0007114512005764 [DOI] [PubMed] [Google Scholar]
- 8.Santos AC, Severo M, Barros H. Incidence and risk factors for the metabolic syndrome in an urban South European population. Prev Med. 2010;50:99–105. 10.1016/j.ypmed.2009.11.011 [DOI] [PubMed] [Google Scholar]
- 9.Wannamethee SG, Shaper AG, Whincup PH. Modifiable lifestyle factors and the metabolic syndrome in older men: effects of lifestyle changes. J Am Geriatr Soc. 2006;54:1909–1914. 10.1111/j.1532-5415.2006.00974.x [DOI] [PubMed] [Google Scholar]
- 10.Kim BJ, Kim BS, Kang JH. Alcohol consumption and incidence of metabolic syndrome in Korean men. A 3-year follow-up study. Circ J. 2012;76:2363–2371. 10.1253/circj.CJ-12-0315 [DOI] [PubMed] [Google Scholar]
- 11.Song M, Giovannucci E. Estimating the influence of obesity on cancer risk: stratification by smoking is critical. J Clin Oncol. 2016;34:3237–3239. 10.1200/JCO.2016.67.6916 [DOI] [PubMed] [Google Scholar]
- 12.Song M, Giovannucci E. Preventable incidence of carcinoma associated with adiposity, alcohol, and physical inactivity according to smoking status in the United States. Int J Cancer. 2020;146:2960–2967. 10.1002/ijc.32602 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Nakashita Y, Nakamura M, Kitamura A, et al. Relationships of cigarette smoking and alcohol consumption to metabolic syndrome in Japanese men. J Epidemiol. 2010;20:391–397. 10.2188/jea.JE20100043 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Slagter SN, van Vliet-Ostaptchouk JV, Vonk JM, et al. Combined effects of smoking and alcohol on metabolic syndrome: the LifeLines cohort study. PLoS One. 2014;9(8):e105157. 10.1371/journal.pone.0105157 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Yu M, Xu CX, Zhu HH, et al. Associations of cigarette smoking and alcohol consumption with metabolic syndrome in a male Chinese population: a cross-sectional study. J Epidemiol. 2014;24:361–369. 10.2188/jea.JE20130112 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Sun K, Ren M, Liu D, et al. Alcohol consumption and risk of metabolic syndrome: a meta-analysis of prospective studies. Clin Nutr. 2014;33:596–602. 10.1016/j.clnu.2013.10.003 [DOI] [PubMed] [Google Scholar]
- 17.Goedde HW, Agarwal DP, Fritze G, et al. Distribution of ADH 2 and ALDH2 genotypes in different populations. Hum Genet. 1992;88:344–346. 10.1007/BF00197271 [DOI] [PubMed] [Google Scholar]
- 18.Kim J, Kim J. Association between fruit and vegetable consumption and risk of hypertension in middle-aged and older Korean adults. J Acad Nutr Diet. 2018;118:1438–1449.e5. 10.1016/j.jand.2017.08.122 [DOI] [PubMed] [Google Scholar]
- 19.Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120:1640–1645. 10.1161/CIRCULATIONAHA.109.192644 [DOI] [PubMed] [Google Scholar]
- 20.World Health Organization. International guide for monitoring alcohol consumption and related harm. Geneva: World Health Organization; 2000. [Google Scholar]
- 21.Kim D, Kim J. Dairy consumption is associated with a lower incidence of the metabolic syndrome in middle-aged and older Korean adults: the Korean Genome and Epidemiology Study (KoGES). Br J Nutr. 2017;117:148–160. 10.1017/S000711451600444X [DOI] [PubMed] [Google Scholar]
- 22.Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32(9)(Suppl):S498–S504. 10.1097/00005768-200009001-00009 [DOI] [PubMed] [Google Scholar]
- 23.Ahn Y, Kwon E, Shim JE, et al. Validation and reproducibility of food frequency questionnaire for Korean genome epidemiologic study. Eur J Clin Nutr. 2007;61:1435–1441. 10.1038/sj.ejcn.1602657 [DOI] [PubMed] [Google Scholar]
- 24.The Korean Nutrition Society. Food composition table. In Recommended Dietary Allowances for Koreans, 7th ed. Seoul. The Korean Nutrition Society; 2000. [Google Scholar]
- 25.Hernán MA, Hernández-Díaz S, Werler MM, et al. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol. 2002;155:176–184. 10.1093/aje/155.2.176 [DOI] [PubMed] [Google Scholar]
- 26.Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239–241. 10.1093/biomet/69.1.239 [DOI] [Google Scholar]
- 27.Gigleux I, Gagnon J, St-Pierre A, et al. Moderate alcohol consumption is more cardioprotective in men with the metabolic syndrome. J Nutr. 2006;136:3027–3032. 10.1093/jn/136.12.3027 [DOI] [PubMed] [Google Scholar]
- 28.Buja A, Scafato E, Sergi G, et al. Alcohol consumption and metabolic syndrome in the elderly: results from the Italian longitudinal study on aging. Eur J Clin Nutr. 2010;64:297–307. 10.1038/ejcn.2009.136 [DOI] [PubMed] [Google Scholar]
- 29.Kovář J, Zemánková K. Moderate alcohol consumption and triglyceridemia. Physiol Res. 2015;64(Suppl 3):S371–S375. 10.33549/physiolres.933178 [DOI] [PubMed] [Google Scholar]
- 30.Mukamal KJ, Mackey RH, Kuller LH, et al. Alcohol consumption and lipoprotein subclasses in older adults. J Clin Endocrinol Metab. 2007;92:2559–2566. 10.1210/jc.2006-2422 [DOI] [PubMed] [Google Scholar]
- 31.Chelland Campbell S, Moffatt RJ, Stamford BA. Smoking and smoking cessation--the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis. 2008;201:225–235. 10.1016/j.atherosclerosis.2008.04.046 [DOI] [PubMed] [Google Scholar]
- 32.Jain RB, Ducatman A. Associations between smoking and lipid/lipoprotein concentrations among US adults aged ≥20 years. J Circ Biomark. 2018;7:1849454418779310. 10.1177/1849454418779310 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Chen CC, Li TC, Chang PC, et al. Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan. Metabolism. 2008;57:544–548. 10.1016/j.metabol.2007.11.018 [DOI] [PubMed] [Google Scholar]
- 34.Koda M, Kitamura I, Okura T, et al. The associations between smoking habits and serum triglyceride or hemoglobin A1c levels differ according to visceral fat accumulation. J Epidemiol. 2016;26:208–215. 10.2188/jea.JE20150086 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Katsuki A, Sumida Y, Urakawa H, et al. Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care. 2003;26:2341–2344. 10.2337/diacare.26.8.2341 [DOI] [PubMed] [Google Scholar]
- 36.Steptoe A, Ussher M. Smoking, cortisol and nicotine. Int J Psychophysiol. 2006;59:228–235. 10.1016/j.ijpsycho.2005.10.011 [DOI] [PubMed] [Google Scholar]
- 37.Lee MJ, Pramyothin P, Karastergiou K, et al. Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity. Biochim Biophys Acta. 2014;1842:473–481. 10.1016/j.bbadis.2013.05.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Canoy D, Wareham N, Luben R, et al. Cigarette smoking and fat distribution in 21,828 British men and women: a population based study. Obes Res. 2005;13:1466–1475. 10.1038/oby.2005.177 [DOI] [PubMed] [Google Scholar]
- 39.Onishi Y, Honda M, Ogihara T, et al. Ethanol feeding induces insulin resistance with enhanced PI 3-kinase activation. Biochem Biophys Res Commun. 2003;303:788–794. 10.1016/S0006-291X(03)00407-8 [DOI] [PubMed] [Google Scholar]
- 40.Funayama T, Tamura Y, Takeno K, et al. Effects of alcohol abstinence on glucose metabolism in Japanese men with elevated fasting glucose: a pilot study. Sci Rep. 2017;7:40277. 10.1038/srep40277 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Bellou V, Belbasis L, Tzoulaki I, et al. Risk factors for type 2 diabetes mellitus: an exposure-wide umbrella review of meta-analyses. PLoS One. 2018;13:e0194127. 10.1371/journal.pone.0194127 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Nakanishi N, Nakamura K, Matsuo Y, et al. Cigarette smoking and risk for impaired fasting glucose and type 2 diabetes in middle-aged Japanese men. Ann Intern Med. 2000;133:183–191. 10.7326/0003-4819-133-3-200008010-00009 [DOI] [PubMed] [Google Scholar]
- 43.Bergman BC, Perreault L, Hunerdosse D, et al. Novel and reversible mechanisms of smoking-induced insulin resistance in humans. Diabetes. 2012;61:3156–3166. 10.2337/db12-0418 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Kim KW, Kang SG, Song SW, et al. Association between the time of length since smoking cessation and insulin resistance in asymptomatic Korean male ex-smokers. J Diabetes Res. 2017;2017:6074760. 10.1155/2017/6074760 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.